Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenue	$ 316	$ 2
Cost of revenue	21,381	20,687
Gross profit	(21,065)	(20,685)
Operating expenses
Research and development	6,419	6,688
Sales and marketing	2,629	2,474
General and administrative	13,674	13,848
Loss (gain) on disposal on property, plant, and equipment	44	(87)
Total operating expenses	22,766	22,923
Loss from operations	(43,831)	(43,608)
Other income, net	1,784	530
Loss before income taxes	(10,268)	(48,217)
Income tax expense	(10)	0
Net loss	(10,278)	(48,217)
Total comprehensive loss
Net loss	(10,278)	(48,217)
Foreign currency translation adjustment	306	232
Total comprehensive loss	$ (9,972)	$ (47,985)
Class A Common Stock
Net loss per share of Class A and B Common Stock attributable to common stockholders:
Basic (in dollars per share)	$ (0.14)	$ (26.23)
Diluted (in dollars per share)	$ (0.14)	$ (26.23)
Weighted average common shares used in computing net loss per share of Class A and Class B Common Stock:
Basic (in shares)	75,749,893	1,837,959
Diluted (in shares)	75,749,893	1,837,959
Class B Common Stock
Net loss per share of Class A and B Common Stock attributable to common stockholders:
Basic (in dollars per share)	$ (0.14)	$ (26.23)
Diluted (in dollars per share)	$ (0.14)	$ (26.23)
Weighted average common shares used in computing net loss per share of Class A and Class B Common Stock:
Basic (in shares)	75,749,893	1,837,959
Diluted (in shares)	75,749,893	1,837,959
Nonrelated Party
Operating expenses
Change in fair value of notes payable, warrant liabilities, and derivative call options	$ 51,458	$ 27,885
Loss on settlement of notes payable	(15,920)	(11,403)
Interest expense	(2,302)	(2,225)
Related Party
Operating expenses
Change in fair value of notes payable, warrant liabilities, and derivative call options	(277)	(7)
Loss on settlement of notes payable	(1,180)	(14,295)
Interest expense	$ 0	$ (5,094)